Generics will continue their domination on the pharmaceutical market in Central and Eastern Europe until 2011 - November 2009

The pharmaceutical market in Central and Eastern Europe is dominated by generic drugs. This subdivision was worth €17.2bn in 2008 and is expected to develop by around 14% per annum between 2009 and 2011. The growth rate of the innovative drug market, which was worth €12.4bn in 2008, will be slower, according to our latest report entitled “Generic and innovative drugs market in Central and Eastern Europe 2009. Comparative analysis, reimbursement policies and development forecasts for 2009-2011”.

To open the FULL free article/document, please sign up.

*required


*Email:
		To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:
Help us better answer your needs. Why do you sign up?		Please specify:
		Privacy Policy

Free e-letters

PMR Publications provides market intelligence for business professionals interested in Central and Eastern European countries as well as other emerging markets. Publications by PMR analyse the business climate in the region. The offer includes both free and paid subscription newsletters, online news & analysis services and in-depth reports on Central and Eastern Europe. PMR Publications is a division of PMR, a British-American company providing market research (through PMR Research), consultancy (through PMR Consulting) and business publications (through PMR Publications).